Cargando…
Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort
INTRODUCTION: Invasive non-typhoidal Salmonellosis (iNTS) is mainly caused by Salmonella enterica serovars Typhimurium and Enteritidis and is estimated to result in 77 500 deaths per year, disproportionately affecting children under 5 years of age in sub-Saharan Africa. Invasive non-typhoidal Salmon...
Autores principales: | Hanumunthadu, Brama, Kanji, Nasir, Owino, Nelly, Ferreira Da Silva, Carla, Robinson, Hannah, White, Rachel, Ferruzzi, Pietro, Nakakana, Usman, Canals, Rocio, Pollard, Andrew J, Ramasamy, Maheshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649500/ https://www.ncbi.nlm.nih.gov/pubmed/37963701 http://dx.doi.org/10.1136/bmjopen-2023-072938 |
Ejemplares similares
-
Towards a Four-Component GMMA-Based Vaccine against Shigella
por: Micoli, Francesca, et al.
Publicado: (2022) -
Opening Salvo
por: Katz, Patricia, et al.
Publicado: (2019) -
GMMA-Based Vaccines: The Known and The Unknown
por: Mancini, Francesca, et al.
Publicado: (2021) -
Salvo el crepúsculo
por: Cortázar, Julio
Publicado: (1994) -
Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial
por: Launay, Odile, et al.
Publicado: (2019)